Table 2. Univariate and Multivariate Analysis of Risk Factors for Poor Outcomes Among HIV infected patients in Addis Ababa, Ethiopia (n = 367).

Characteristic		Univariate Analysis				Multivariate Analysis
		OR (95% CI)		P		OR (95% CI)		P
Cryptococcal Antigen Positive		0.77 (0.22–2.65)		0.68		1.27 (0.33–4.83)		0.73
Demographics
Mean Age in years (IQR)		0.98 (0.94–1.01)		0.20
Male		1.28 (0.68–2.41)		0.44
BMI <18.5 kg/m2		1.71 (0.88–3.31)		0.11
Site 1 vs. 2		1.23 (0.60–2.54)		0.57
ART Use
ART at Baseline		0.41 (0.21–0.78)		0.01
ART at Follow Up		0.04 (0.02–0.09)		<.001		0.06 (0.02–0.19)		<.0001
CD4 Count Status
CD4<100 vs. 100–200 at Baseline		2.97 (1.56–5.63)		0.001		3.04 (1.37–6.73)		<.006
Increase in CD4 count		0.08 (0.04–.17)		<.001		0.12 (0.05–.27)		<.0001
Opportunistic Infections
Treated for TB at Baseline or during FU	0.96 (0.36–2.59)		0.94
Treated for Pneumonia at baseline or during FU	0.99 (0.37–2.67)		0.99
Herpes Zoster at baseline or during FU	1.25 (0.46–3.41)		0.66

BMI, body mass index; ART, antiretroviral therapy; TB, tuberculosis; FU, follow-up.